Leukotrienes and atherosclerosis: new roles for old mediators
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 25 (6) , 315-322
- https://doi.org/10.1016/j.it.2004.04.003
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Amino Acid Differences in the Deduced 5-Lipoxygenase Sequence of CAST Atherosclerosis-Resistance Mice Confer Impaired Activity When Introduced Into the Human OrthologArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout MiceCirculation, 2003
- Targeted Gene Disruption Reveals the Role of Cysteinyl Leukotriene 1 Receptor in the Enhanced Vascular Permeability of Mice Undergoing Acute Inflammatory ResponsesJournal of Biological Chemistry, 2002
- Characterization of Mouse Cysteinyl Leukotriene Receptors mCysLT1 and mCysLT2Journal of Biological Chemistry, 2002
- A Novel Hepatointestinal Leukotriene B4 ReceptorPublished by Elsevier ,2000
- Cloning and Characterization of cDNA Encoding a Novel Human Leukotriene B4 ReceptorBiochemical and Biophysical Research Communications, 2000
- Collagen-induced Arthritis Is Reduced in 5-Lipoxygenase-activating Protein-deficient MiceThe Journal of Experimental Medicine, 1997
- Isoleukotrienes Are Biologically Active Free Radical Products of Lipid PeroxidationPublished by Elsevier ,1995
- Lipoxins and Other Lipoxygenase Products with Relevance to Inflammatory Reactions in the LungAnnals of the New York Academy of Sciences, 1991
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980